Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies
JNCI Cancer Spectrum · 04.01.2024 · 8 (1)
DOI: 10.1093/jncics/pkad104 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 09.12.2023. Verfasst von M Diana van Die und 6 weiteren Autor:innen. Beteiligte Einrichtung: NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Phytonutrient intakes may improve outcomes following breast cancer, but the impact of postdiagnosis introduction vs established prediagnostic exposure as well as optimum doses has not been established. Evidence from observational studies for key exposures was evaluated, including dosage and intake time frames.
Methods
MEDLINE, EMBASE, CINAHL, Cochrane Library, ClinicalTrials.gov, and the ISRCTN registry were searched for prospective and retrospective observational studies investigating the impact of soybean, lignans, cruciferous (cabbage-family) vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. A random-effects model was used to calculate summary hazard ratios (HRs) and 95% confidence intervals (CIs). Nonlinear dose-response analyses were conducted using restricted cubic splines.
Results
Thirty-two articles were included. Soy isoflavones were associated with a 26% reduced risk of recurrence (HR = 0.74, 95% CI = 0.60 to 0.92), particularly among postmenopausal (HR = 0.72, 95% CI = 0.55 to 0.94) and estrogen receptor–positive survivors (HR = 0.82, 95% CI = 0.70 to 0.97), with the greatest risk reduction at 60 mg/day. In mortality outcomes, the reduction was mostly at 20 to 40 mg/day. Soy protein and products were inversely associated with cancer-specific mortality for estrogen receptor–positive disease (HR = 0.75, 95% CI = 0.60 to 0.92). An inverse association was observed for serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, with cancer-specific mortality (HR = 0.72, 95% CI = 0.58 to 0.90) and all-cause mortality (HR = 0.69, 95% CI = 0.57 to 0.83). No effects were observed for cruciferous vegetables. There was a 44% reduced risk of recurrence with prediagnostic green tea for stage I and II breast cancer (HR = 0.56, 95% CI = 0.38 to 0.83).
Conclusions
Soy, enterolactone, and green tea demonstrated significant risk reductions in outcomes following breast cancer. Evidence is needed regarding the impact of postdiagnostic introduction or substantial increase of these exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia.
- Integria (MediHerb), Warwick, QLD, Australia.
- Northeast College of Health Sciences, Seneca Falls, NY, USA.
- Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Baltimore, MD, USA.
- Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
- Department of Diet, Cancer and Health, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
ORCID-Profile: M Diana van Die, Cecile Kyrø, Dagfinn Aune, Channing J Paller
Zitieren
APA
van Die, M. D., Bone, K. M., Visvanathan, K., Kyrø, C., Aune, D., Ee, C., & Paller, C. J. (2024). Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI Cancer Spectrum, 8(1). https://doi.org/10.1093/jncics/pkad104
Vancouver
van Die MD, Bone KM, Visvanathan K, Kyrø C, Aune D, Ee C, et al. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI Cancer Spectrum. 2024;8(1). doi:10.1093/jncics/pkad104
BibTeX
@article{vanDie2024,
author = {van Die, M Diana and Bone, Kerry M and Visvanathan, Kala and Kyrø, Cecile and Aune, Dagfinn and Ee, Carolyn and Paller, Channing J},
title = {Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {1},
doi = {10.1093/jncics/pkad104}
}
EUVIMED